NOVONIX Ltd current report, Q4 FY2023

NOVONIX Limited Form 6-K Summary

Business context and reporting period

NOVONIX Limited filed a Form 6-K for December 2023, dated December 12, 2023. The filing identifies NOVONIX as an Australian foreign private issuer that files annual reports on Form 20-F.

Filing contents

The filing contains one exhibit: Exhibit 99.1, an Appendix 3H titled “Notification of Cessation of Securities,” dated December 12, 2023. The provided filing text does not include the underlying exhibit details or identify the securities affected.

Financial metrics and material changes

The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, financial guidance, or other financial metrics. It also does not clearly describe material changes versus a prior comparable period.

Outlook, risks, and unusual items

No management outlook, risk discussion, contingencies, or unusual operating items are included in the provided text. The cessation of securities notification may represent a material securities-related event, but its nature and implications cannot be determined without Exhibit 99.1.

Investor verification items

  • Review Exhibit 99.1 to identify the securities that ceased and the effective date.
  • Verify the reason for the cessation and whether it affects outstanding shares, options, warrants, or other securities.
  • Assess any related dilution, listing, registration, or capitalization implications.
  • Consult NOVONIX’s applicable Form 20-F and subsequent filings for financial results, liquidity, risks, and guidance.